Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/21/2003WO2002039994A3 Methods for the treatment and prevention of urinary stone disease
08/21/2003WO2002036615A3 Methods for producing and improving therapeutic potency of binding polypeptides
08/21/2003WO2002036611A3 Immunomodulatory peptides derived from heat shock proteins and uses thereof
08/21/2003WO2002036162A3 Compositions for treatment of ocular neovascularization and neural injury
08/21/2003WO2002036141A3 Method of enhancing lymphocyte-mediated immune responses
08/21/2003WO2002035240A3 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
08/21/2003WO2002029083A3 Industrial-scale serum-free production of recombinant proteins in mammalian cells
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002020047A9 Chlamydial peptides and their mimics in demyelinating disease
08/21/2003WO2002010392A9 Mammalian dna binding membrane-associated protein-encoding gene and uses
08/21/2003WO2002006344A3 Rtvp based compositions and methods for the treatment of prostate cancer
08/21/2003WO2002006343A3 Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau
08/21/2003WO2002004009A3 Method for treating cancer using an interleukin- 4 antagonist
08/21/2003WO2002000717A3 Novel co-stimulatory molecules
08/21/2003WO2001092581A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
08/21/2003WO2001090342A3 Genetic engineering of vascular grafts to resist disease
08/21/2003WO2001085792A3 Mu-1, member of the cytokine receptor family
08/21/2003WO2001079479A3 Methods for selective targeting
08/21/2003WO2001060162A9 Cationic, amphipathic beta-sheet peptides and uses thereof
08/21/2003US20030159162 Methods of using transporter-like molecules to treat pain and pain-related disorders
08/21/2003US20030159158 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders
08/21/2003US20030158602 Contacting a cell containing a NELL-1 gene with a test agent; and detecting a change in the expression level of Nell-1 gene as compared to the expression of the NELL-1 gene in a cell that is not contacted with test agent
08/21/2003US20030158414 Process for preparing growth hormone secretagogues
08/21/2003US20030158402 Stimulant immunology response; prevent infections
08/21/2003US20030158400 Antiinflammatory agents; autoimmune disease; rheumatic diseases; genetic engineered cells
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158396 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
08/21/2003US20030158392 IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use therefor
08/21/2003US20030158390 Protein; Escherichia culture product; genetic engineering; fusion
08/21/2003US20030158389 Immunoglobulins; genetic engineering
08/21/2003US20030158387 Processed human chemokines PHC-1 and PHC-2
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158379 A DNA molecules encoding the proteins, used in the treatment of bone, connective tissue, tendon, ligament, wound healing and defects to tissues, animal growth factors, cell differentiation of embryonic and stem cells
08/21/2003US20030158378 Polypeptides; genetic engineering
08/21/2003US20030158376 Relaxin-like factor and methods and uses thereof
08/21/2003US20030158375 Neutrophil stimulant; granulocyte colony stimulating factor; genetic engineering
08/21/2003US20030158248 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide
08/21/2003US20030158236 Treating, e.g., an HIV infection.
08/21/2003US20030158223 Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158159 Administering a calcitonin-like agent and a dehydroepiandrosterone-like agent to treat an indivisual for bone density loss
08/21/2003US20030158152 Protease inhibitors and their pharmaceutical uses
08/21/2003US20030158149 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold
08/21/2003US20030158144 Antisense modulation of estrogen receptor beta expression
08/21/2003US20030158143 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers
08/21/2003US20030158142 For screening for compounds which affects apoptosis
08/21/2003US20030158139 Decreasing adipose mass by altering RSK2 activity
08/21/2003US20030158136 Materials and methods relating to immune responses to fusion proteins
08/21/2003US20030158133 Use of such inhibitors or activators in treatment of dilated cardiomyopathy, pulmonary hypertension and/or other medical conditions related to PDE3 effects on cAMP levels in different intracellular compartments
08/21/2003US20030158127 Aromatic sulfenates for type I phototherapy
08/21/2003US20030158121 Novel $G(y)crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same
08/21/2003US20030158120 Combination product comprising melagatran and a factor xa inhibitor
08/21/2003US20030158118 For therapy of cancer, chemoprevention or the suppression of hypersensitivity and inflammatory reactions
08/21/2003US20030158117 Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals
08/21/2003US20030158116 Peptides and compounds that bind to a receptor
08/21/2003US20030158114 Administering to a subject in need of such treatment, an agent in an amount effective to inhibit proliferation
08/21/2003US20030158113 Administering to individual a therapeutically effective amount of osteopontin or a functional fragment
08/21/2003US20030158112 Selective induction of apoptosis to treat ocular disease
08/21/2003US20030158111 Contacting animal's mouth tissue with peptide
08/21/2003US20030158110 Vasoactive intestinal peptide analogs
08/21/2003US20030158108 For use as immuno-suppressive drugs; for therapy of pathologies that involve a dysfunction of calcium channels
08/21/2003US20030158107 Preparation of a therapeutic composition
08/21/2003US20030158106 Use of fsh for treating infertility
08/21/2003US20030158105 Determining polypeptide sequence of at least one Bcr-Abl polypeptide expressed by the human cancer cell and comparing the polypeptide sequence of the Bcr-Abl polypeptide expressed by the human cancer cell to the Bcr-Abl polypeptide sequence
08/21/2003US20030158104 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030158103 Administering to the animal an amount of growth hormone effective to reduce incidence of infection by bacterial and viral pathogens, wherein amount of growth hormone is not sufficient to promote growth
08/21/2003US20030158102 ICOS mutants
08/21/2003US20030158101 Glucagon-like peptide-2 and its therapeutic use
08/21/2003US20030158100 For use in therapy
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158098 Colon specific gene and protein
08/21/2003US20030158096 Novel molecule
08/21/2003US20030158095 Method of using lectins for therapy of diseases transmittable by sexual contact
08/21/2003US20030158094 Combination product of an aryl-substituted propanolamine derivative with at least one other active ingredient and the use of the product
08/21/2003US20030158092 For therapy of glycoprotein aberration disorders (e.g., cystic fibrosis), including gene therapy
08/21/2003US20030158091 Increasing function of organs having reduced red blood cell flow
08/21/2003US20030158090 Renin-angiotensin system in diabetes mellitus
08/21/2003US20030158087 Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases
08/21/2003US20030158086 For use in therapy ofweak immunity and immunodeficiencies, hormonal disorders, as a nutrient for skin, hair, nails, in food supplements, cosmetics
08/21/2003US20030158085 For diagnosis and therapy of pancreatic disorders, particularly type I diabetes
08/21/2003US20030157717 Linear DNA fragments for gene expression
08/21/2003US20030157712 Initiating, promoting and/or directing cell attachment to a matrix or to another cell comprising tyrosine kinase receptors/ephrin-b1 (EPHB) for inhibiting leukocyte/platelet migration/attachment; neovascularization
08/21/2003US20030157691 Producing genetically engineered retrovirus comprising small interfering RNA (SiRNA) for prevention and treatment of human lymphadenopathy associated viral diseases
08/21/2003US20030157690 Fusion protein delivery system and uses thereof
08/21/2003US20030157687 Comprises nucleotide sequences coding enzyme inhibitor (TIMP-4) for treatment of arthritis, cancer and scarring
08/21/2003US20030157686 Comprises polypeptide which affects blood coagulation and platelet aggregation for treatment of blood/hemostatic disorders
08/21/2003US20030157685 Comprises nucleotide sequences coding retinoblastoma-interacting myosin-like gene (RIM), serine protease (OMI) and oncogene protein (NMI) for use as anticarcinogenic/antiproliferative agents
08/21/2003US20030157678 Mitogenic oxygenases
08/21/2003US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003US20030157648 Membrane binding polypeptides derived from urogenital and placenta tissue for monitoring and detecting modulators of ligand bind activity; drug screening
08/21/2003US20030157647 Comprises calcium/glutamate receptor chimera comprising extracellular domain of G-protein coupled membrane protein for treating nervous system disorders
08/21/2003US20030157644 Comprises amino acid sequences fused to polyclonal/monoclonal antibody for detecting modulators and monitoring G-protein binding activity; high throughput assays
08/21/2003US20030157638 Comprises microbiocidal protein for treating ear and vision defects; contraceptives
08/21/2003US20030157633 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
08/21/2003US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 ... 3163